Evidence map›Paper›PMID 31992661›Full record

ArticleTobacco control2020

PhenX: Vector measures for tobacco regulatory research.

Kurt M Ribisl, Frank J Chaloupka, Thomas R Kirchner, Lisa Henriksen, Destiney S Nettles, Rebecca C Geisler, Tabitha P Hendershot, Gary E Swan, PhenX TRR Vector Working Group

Open access · bronzeAbstract read
In one paragraph

Article in Tobacco control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Comorbidity and Familial Aggregation of Mood Disorders and Cigarette Smoking in a Controlled Family Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Epidemiological Model for Conventional Tobacco Control Measures and Tobacco Endgame Policies.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Kurt M RibislHealth Behavior, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA kurt_ribisl@unc.edu.
Frank J ChaloupkaEconomics, University of Illinois at Chicago, Chicago, Illinois, USA.
Thomas R KirchnerCollege of Global Public Health, New York University, New York City, New York, USA.
Lisa HenriksenStanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
Destiney S NettlesRTI International, Research Triangle Park, North Carolina, USA.
Rebecca C GeislerRTI International, Research Triangle Park, North Carolina, USA.
Tabitha P HendershotRTI International, Research Triangle Park, North Carolina, USA.
Gary E SwanStanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
PhenX TRR Vector Working Group
RTI International · USStanford University · USDepartment of Health · ZANew York University · USUniversity of Illinois Chicago · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Genomic Resource Grant for the PhenX Toolkit - expansion and sustainabilityPhenX Supplement for COVID-19 ResearchU41HG007050 · NHGRI · RESEARCH TRIANGLE INSTITUTE · PI HAMILTON, CAROL MARIE · 2013 to 2022
$21.2M
NCI NIH HHS P30 CA016086NHGRI NIH HHS U41 HG007050
6 · The paper itself

Abstract

The PhenX (Phenotypes and eXposures) Toolkit provides researchers with recommended standard consensus measures for use in epidemiological, biomedical, clinical and translational studies. To expand the depth and breadth of measures in the PhenX Toolkit, the National Institutes of Health and U.S. Food and Drug Administration have launched a project to identify 'Core' and 'Specialty' collections of measures recommended for human subjects studies in tobacco regulatory research (TRR). The current paper addresses the PhenX Toolkit TRR Vector specialty area and describes the 6-month process to identify high-priority, low-burden, scientifically supported consensus measures. Self-reported, interviewer-administered and observational measurements were considered, and input from the research community assisted in justifying the inclusion of 13 tobacco industry-relevant measures (mainly interviewer-administered or self-reported measures) in the PhenX Toolkit. Compared with measures of addiction or the use of tobacco products, assessments of many Vector factors are much newer and at an earlier stage of development. More work is needed to refine and validate measures of the spatial distribution of tobacco retailers, retail environment, price promotions and corporate social responsibility.

Indexed as

Advisory CommitteesCommerceConsensusData CollectionEpidemiologic StudiesHumansMarketingResearch DesignSelf ReportSoftwareTobacco IndustryTobacco ProductsTobacco Useadvertising and promotionmediapricetobacco industry

Identifiers

PMID31992661
PMCPMC7842080
OpenAlexW3004319293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.